Himmelreich G, Riewald M, Rosch R, Blumhard G, Neuhaus P, Roissant R, Riess H
Department of Internal Medicine, University Clinic Rudolf Virchow, Berlin, Germany.
Am J Hematol. 1994 Sep;47(1):1-5. doi: 10.1002/ajh.2830470102.
Thrombomodulin is a surface protein of vascular endothelial cells. A smaller form of thrombomodulin in blood and urine, the soluble (s)thrombomodulin, appears to be derived from injured endothelial cells or to be proteolytically cleaved from thrombomodulin by proteases. Several in vitro and in vivo studies have suggested (s)thrombomodulin as a marker of endothelial damage. In orthotopic liver transplantation, platelet and leukocyte activation as well as prothrombin activation are suspected of being caused by damaged endothelial cells in the graft liver. We determined (s)thrombomodulin antigen as well as thrombin-antithrombin III complexes, protein C, and antithrombin III activities in the course of 23 orthotopic liver transplantations. Samples were taken at 7 different time-points intraoperatively, as well as out of the perfusate released from the graft liver vein during the flushing procedure with arterial blood prior to the opening of the hepatocaval anastomosis. Levels of (s)thrombomodulin antigen and thrombin-antithrombin III complexes showed a significant increase with reperfusion of the graft liver and levels in the perfusate were higher (both: P = 0.0001) than the corresponding systemic levels. In parallel, antithrombin III decreased significantly with reperfusion and perfusate levels of antithrombin III and protein C activities were lower in the systemic circulation (both: P = 0.0001). In conclusion, high levels of (s)thrombomodulin antigen in the early reperfusion phase and in the perfusate strongly indicate endothelial damage to the graft liver vascular bed, paralleled and followed by signs of prothrombin activation.
血栓调节蛋白是血管内皮细胞的一种表面蛋白。血液和尿液中存在一种较小形式的血栓调节蛋白,即可溶性血栓调节蛋白(s血栓调节蛋白),它似乎来源于受损的内皮细胞,或者是由蛋白酶对血栓调节蛋白进行蛋白水解切割产生的。多项体外和体内研究表明,s血栓调节蛋白可作为内皮损伤的标志物。在原位肝移植中,血小板和白细胞激活以及凝血酶原激活被怀疑是由移植肝中受损的内皮细胞引起的。我们测定了23例原位肝移植过程中s血栓调节蛋白抗原以及凝血酶 - 抗凝血酶III复合物、蛋白C和抗凝血酶III的活性。术中在7个不同时间点取样,同时在肝腔静脉吻合口开放前用动脉血冲洗时,从移植肝静脉释放的灌注液中取样。s血栓调节蛋白抗原和凝血酶 - 抗凝血酶III复合物的水平在移植肝再灌注时显著升高,灌注液中的水平高于相应的全身水平(两者均为P = 0.0001)。同时,抗凝血酶III随着再灌注显著降低,全身循环中抗凝血酶III的灌注液水平和蛋白C活性较低(两者均为P = 0.0001)。总之,再灌注早期和灌注液中高水平的s血栓调节蛋白抗原强烈提示移植肝血管床存在内皮损伤,同时伴有凝血酶原激活的迹象并随后出现。